Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
35.8M
-
Shares change
-
+4.19M
-
Total reported value, excl. options
-
$195M
-
Value change
-
+$23.8M
-
Put/Call ratio
-
2.17
-
Number of buys
-
87
-
Number of sells
-
-40
-
Price
-
$5.44
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2024
166 filings reported holding HUMA - Humacyte, Inc. - COM as of Q3 2024.
Humacyte, Inc. - COM (HUMA) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (7.54M shares), VANGUARD GROUP INC (5.06M shares), STATE STREET CORP (4.76M shares), GEODE CAPITAL MANAGEMENT, LLC (2.04M shares), MILLENNIUM MANAGEMENT LLC (1.27M shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (1.26M shares), TWO SIGMA INVESTMENTS, LP (1.07M shares), Woodline Partners LP (849K shares), GOLDMAN SACHS GROUP INC (833K shares), and NORTHERN TRUST CORP (808K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.